review

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™…

2 months ago

Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review

TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a…

2 months ago

HUTCHMEDAnnounces NDA Acceptance in China with Priority Review Status for ORPATHYSand TAGRISSOCombination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFRInhibitorTherapy

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…

2 months ago

Just published Olympic Review begins the countdown to Milano Cortina 2026

18 December 2024 - A little over a year from now, Italy will welcome the world to the Olympic Winter Games…

3 months ago

Just published Olympic Review begins the countdown to Milano Cortina 2026

18 December 2024 - A little over a year from now, Italy will welcome the world to the Olympic Winter Games…

3 months ago

Telecom Review Leaders’ Summit: The world’s first 5G-A region sets sail for the Mobile AI Era

DUBAI, United Arab Emirates, Dec. 14, 2024 /PRNewswire/ -- The panel at Telecom Review Leaders' Summit 18th edition, titled 'World…

3 months ago

Telecom Review Leaders’ Summit: The world’s first 5G-A region sets sail for the Mobile AI Era

DUBAI, United Arab Emirates, Dec. 14, 2024 /PRNewswire/ -- The panel at Telecom Review Leaders' Summit 18th edition, titled 'World…

3 months ago

Telecom Review Leaders’ Summit: The world’s first 5G-A region sets sail for the Mobile AI Era

DUBAI, United Arab Emirates, Dec. 14, 2024 /PRNewswire/ -- The panel at Telecom Review Leaders' Summit 18th edition, titled 'World…

3 months ago

EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

PROVIDENCE, R.I., Dec. 7, 2024 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics,…

3 months ago

EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

PROVIDENCE, R.I., Dec. 7, 2024 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics,…

3 months ago